Skip to content
Screener

R&D at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$364M
Danaher logo
DanaherDHR
$412M+2.2%
Illumina logo
IlluminaILMN
$252M+2.0%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$4.85M+17.8%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$19.7M-17.7%
BioLife Solutions logo
BioLife SolutionsBLFS
$2.96M+50.5%

Other financials

Income statement

See full
Revenue$161.2M+12.0%
Gross profit$72.4M+9.0%
Operating income-$4.2M-126%
Net income$2.5M+105%
EPS (diluted)$0.05+105%

Balance sheet

See full
Cash & equivalents$70.8M
Total debt$54.0M
Total equity$1.5B-9.7%
Total assets$1.9B

Cash flow

See full
Operating cash flow$1.4M-94.4%
CapEx$6.6M-38.7%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.48B+15.1%
Enterprise value$1.46B
P/S2.4×+0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-20%+1.5pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-7.7%
Debt / equity
Current ratio2.5×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Azenta’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054295
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Nine Months Ended June 30, 2026Nine Months Ended June 30, 2025
Total cost of revenue88,82277,451256,518236,623
Gross profit72,35666,404198,097198,006
Operating expenses
Research and development8,8537,41727,47522,132
Selling, general and administrative67,16860,083195,666199,854
Impairment of goodwill and intangible assets149,083
Restructuring charges5137543,0784,765
Total operating expenses76,53468,254375,302226,751

Item 1. Financial Statements

FAQ

What is Azenta's R&D?
Azenta (AZTA) reported R&D of $8.85M in Q2 2026.
How has Azenta's R&D changed year-over-year?
Azenta's R&D increased by 19.4% year-over-year, from $7.42M to $8.85M.
What is the long-term trend for Azenta's R&D?
Over 2 years (2021 to 2023), Azenta's R&D has grown at a 23.1% compound annual growth rate (CAGR), from $22.41M to $33.96M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about Azenta's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude